ArticleThoracic cancer2025

Tepotinib for the Treatment of Lung Adenocarcinoma Harboring MET Y1003N Point Mutation: A Case Report.

Yukihiro Umeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.